CCHR has documented psychosis and violent behavior linked to any dose of the drugs and wants them prohibited as a treatment for the 3.1 million American children put at risk by taking them. By CCHR ...
TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced that it is changing its name to Scienture Holdings, Inc.
The development of biological drugs such as gene and cell therapies and vaccines is boosting the production of injectable drug products in the global healthcare market. Chronic illnesses, an ageing ...